Santa Fe Partners’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Santa Fe Partners’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-25,452	Closed	-$1.1M	–	628
2015 Q3	$1.1M	Sell	25,452 -5,908	-19%	-$249K	0.15%	264
2015 Q2	$1.33M	Buy	+31,360	New	+$1.32M	0.18%	231
2014 Q4	–	Sell	-9,986	Closed	-$351K	–	657
2014 Q3	$351K	Buy	+9,986	New	+$342K	0.05%	436

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Santa Fe Partners's WX Position: Q4 2015 in Review

Santa Fe Partners sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 25,452 shares — an estimated $1.1M sold.

Santa Fe Partners first reported a position in WX in Q3 2014 and held it in 3 quarters. The position peaked at $1.33M in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Santa Fe Partners reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Santa Fe Partners sold 25,452 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $1.1M.
Santa Fe Partners first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2014 and held it in 3 quarters.
Santa Fe Partners's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.33M in Q2 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Santa Fe Partners's 13F filing for Q4 2015, filed 12 Feb 2016.